Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof

Patent No. EP3054929 (titled "Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof") was filed by Impax Laboratories on Oct 7, 2014. The application was issued on Aug 5, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LUIGIMay 5, 2021TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3054929

IMPAX LABORATORIES
Application Number
EP14851749A
Filing Date
Oct 7, 2014
Status
Revoked
May 14, 2025
Publication Date
Aug 5, 2020